<DOC>
	<DOCNO>NCT01952483</DOCNO>
	<brief_summary>Assessing immune activation MS patient deficient Vitamin D whether Vitamin D supplementation reverse immune activation Evaluating whether Vitamin D deficiency result lower cognitive performance MS patient effect Vitamin D supplementation reverse cognitive impairment ?</brief_summary>
	<brief_title>Effect Vitamin D Replacement Immune Function Cognition MS Patients</brief_title>
	<detailed_description>We compare immune response patient Vitamin D deficiency ( serum level &lt; 20ng/ml ) patient normal Vitamin D ( serum level &gt; 35 ng/ml ) . We focus proliferation cytokine production myelin basic protein ( MBP ) myelin oligodendrocyte glycoprotein ( MOG ) peptides percentage Th1 ( IFN gamma produce cell ) Th17 ( IL-17 produce cell ) vitro polarization assay . Our hypothesis patient low Vitamin D increase proliferation MBP MOG increase production pro-inflammatory cytokine ( IFN gamma IL-17 ) Vitamin D supplementation decrease pro-inflammatory profile . We measure cognitive performance patient Vitamin D deficiency ( serum level &lt; 20ng/ml ) compare patient normal Vitamin D ( serum level &gt; 35 ng/ml ) adjust educational level disease duration . We hypothesize low Vitamin D negative effect cognitive performance Vitamin D supplementation improve cognitive function .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>1 . Definite diagnosis Multiple Sclerosis follow revise McDonald MS diagnostic criterion 2 . Male Female Aged 18 3 . On interferonβ treatment ( Rebif® , Avonex® , Betaseron® ) 4 . No sign active inflammation attack new lesion MRI 1 . Treatment immune modulating/ suppressive drug IFNb within 6 week prior enrolment 2 . Pregnancy 3 . Hypercalcemia 4. eglomerular filtration rate &lt; 60 5 . History primary hyperparathyroidism , hypercalcemia , renal dysfunction , cardiac disease , malignancy , granulomatous disease 6 . The occurrence exacerbation ( defined episode neurologic dysfunction last least 24 hour ) within 4 week enrollment 7 . History dementia relate disorder 8 . History traumatic brain injury 9 . Diagnosis epilepsy history seizure 10 . Diagnosis psychiatric disease , substance abuse/dependence , alcohol abuse/dependence 11 . Currently , follow medication Lithium , Thiazide diuretic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Multiple Sclerosis ( MS )</keyword>
</DOC>